| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |